Baudax Bio, Inc. filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the Eastern District of Pennsylvania on February 22, 2024. The debtor listed its assets of $0.05 million and liabilities in the range of $16.23 million. The debtor is represented by David B. Smith of Smith Kane Holman, LLC as its legal counsel.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 USD | -7.49% | 0.00% | -54.55% |
Feb. 22 | Baudax Bio, Inc. Filed for Bankruptcy | CI |
2023 | Baudax Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-54.55% | 525K | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- BXRXQ Stock
- News Baudax Bio, Inc.
- Baudax Bio, Inc. Filed for Bankruptcy